BioMarin Pharmaceutical Inc. buy Cantor Fitzgerald
Start price
13.09.23
/
50%
€85.26
Target price
13.09.24
€111.79
Performance (%)
-16.35%
Price
17.05.24
€71.32
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -16.35%. This prediction currently runs until 13.09.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -6.355% | -6.355% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Cantor_Fitzgerald for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $120.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.58
25.04.24
25.04.24
€102.61
25.04.25
25.04.25
-6.87%
17.05.24
17.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€84.34
23.02.24
23.02.24
€92.36
23.02.25
23.02.25
-15.44%
17.05.24
17.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.34
16.10.23
16.10.23
€113.65
16.10.24
16.10.24
-11.23%
17.05.24
17.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€109.34
01.08.24
01.08.24
-10.54%
17.05.24
17.05.24